BENJAMIN MATTHEWS: Open Payments
NPI 1205372604 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,956 in 169 payments from 18 companies in 2025. Trend: 2023 $3,683 · 2024 $3,143 · 2025 $2,956
Food & beverage: $2,956
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $660 |
| Janssen Biotech, Inc. | 39 | $612 |
| UCB, Inc. | 17 | $365 |
| Novartis Pharmaceuticals Corporation | 20 | $285 |
| Amgen Inc. | 8 | $170 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $163 |
| Organon LLC | 12 | $162 |
| Lilly USA, LLC | 6 | $146 |
| GENZYME CORPORATION | 3 | $100 |
| Arcutis Biotherapeutics, Inc. | 4 | $64 |
Products named: TREMFYA, SKYRIZI, Bimzelx, RINVOQ, COSENTYX, OTEZLA, TALTZ, DUPIXENT.
Industry payments across WA — which companies pay providers there.
